Literature DB >> 19723730

Part D and dually eligible patients with mental illness: medication access problems and use of intensive services.

Haiden A Huskamp1, Joyce C West, Donald S Rae, Maritza Rubio-Stipec, Darrel A Regier, Richard G Frank.   

Abstract

OBJECTIVE: This study examined the occurrence of medication access problems and use of intensive mental health services after the transition in January 2006 from Medicaid drug coverage to Medicare Part D for persons dually eligible for Medicaid and Medicare benefits.
METHODS: Psychiatrists randomly selected from the American Medical Association's Physicians Masterfile reported on experiences of one systematically selected dually eligible patient (N=908) in the nine to 12 months after Part D implementation. Propensity score matching was used to compare use of psychiatric emergency department care and inpatient care between individuals who experienced a problem accessing a psychiatric medication after Part D and those who did not.
RESULTS: Approximately 44% of dually eligible patients were reported to have experienced a problem accessing medications. The likelihood of visiting an emergency department was significantly higher for those who experienced an access problem than for those who did not (mean odds ratio=1.75, mean p=.003). There was no difference in number of emergency department visits or hospitalizations for those who had at least one.
CONCLUSIONS: Many dually eligible patients had difficulty accessing psychiatric medications after implementation of Part D. These patients were significantly more likely to visit psychiatric emergency departments than patients who did not experience difficulties. These findings raise concerns about possible negative effects on quality of care. Additional study is needed to understand the full effects of Part D on outcomes and functioning as well as treatment costs for this population.

Entities:  

Mesh:

Year:  2009        PMID: 19723730      PMCID: PMC2768558          DOI: 10.1176/ps.2009.60.9.1169

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  18 in total

1.  Mental health in the Medicare Part D drug benefit: a new regulatory model?

Authors:  Julie Donohue
Journal:  Health Aff (Millwood)       Date:  2006 May-Jun       Impact factor: 6.301

2.  Involuntary out-patient commitment and reduction of violent behaviour in persons with severe mental illness.

Authors:  J W Swanson; M S Swartz; R Borum; V A Hiday; H R Wagner; B J Burns
Journal:  Br J Psychiatry       Date:  2000-04       Impact factor: 9.319

3.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

4.  Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.

Authors:  D Robinson; M G Woerner; J M Alvir; R Bilder; R Goldman; S Geisler; A Koreen; B Sheitman; M Chakos; D Mayerhoff; J A Lieberman
Journal:  Arch Gen Psychiatry       Date:  1999-03

5.  Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey.

Authors:  A F Lehman; D M Steinwachs
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

6.  Comparison of psychiatrists and psychologists in clinical practice.

Authors:  David P Pingitore; Richard M Scheffler; Tetine Sentell; Joyce C West
Journal:  Psychiatr Serv       Date:  2002-08       Impact factor: 3.084

7.  First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients.

Authors:  Joyce C West; Joshua E Wilk; Donald S Rae; Irvin L Muszynski; Maritza Rubio-Stipec; Carol L Alter; Karen E Sanders; Stephen Crystal; Darrel A Regier
Journal:  J Clin Psychiatry       Date:  2009-11-17       Impact factor: 4.384

8.  Symptom profiles and homelessness in schizophrenia.

Authors:  L A Opler; C L Caton; P Shrout; B Dominguez; F I Kass
Journal:  J Nerv Ment Dis       Date:  1994-03       Impact factor: 2.254

9.  The evolution of insight, paranoia and depression during early schizophrenia.

Authors:  R J Drake; A Pickles; R P Bentall; P Kinderman; G Haddock; N Tarrier; S W Lewis
Journal:  Psychol Med       Date:  2004-02       Impact factor: 7.723

10.  Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia.

Authors:  Peter J Weiden; Chris Kozma; Amy Grogg; Julie Locklear
Journal:  Psychiatr Serv       Date:  2004-08       Impact factor: 3.084

View more
  5 in total

1.  Persistent medication affordability problems among disabled Medicare beneficiaries after Part D, 2006-2011.

Authors:  Huseyin Naci; Stephen B Soumerai; Dennis Ross-Degnan; Fang Zhang; Becky A Briesacher; Jerry H Gurwitz; Jeanne M Madden
Journal:  Med Care       Date:  2014-11       Impact factor: 2.983

2.  Effects of Medicare Part D on guideline-concordant pharmacotherapy for bipolar I disorder among dual beneficiaries.

Authors:  Marguerite E Burns; Alisa B Busch; Jeanne M Madden; Robert F Le Cates; Fang Zhang; Alyce S Adams; Dennis Ross-Degnan; Stephen B Soumerai; Haiden A Huskamp
Journal:  Psychiatr Serv       Date:  2014-03-01       Impact factor: 3.084

Review 3.  Changes in drug use and out-of-pocket costs associated with Medicare Part D implementation: a systematic review.

Authors:  Jennifer M Polinski; Elaine Kilabuk; Sebastian Schneeweiss; Troyen Brennan; William H Shrank
Journal:  J Am Geriatr Soc       Date:  2010-09       Impact factor: 5.562

4.  Roles of community helpers in using the Medicare Part D benefit.

Authors:  Melissa Anne Hensley
Journal:  J Health Care Poor Underserved       Date:  2011-02

5.  Impact of Medicare Part D on mental health treatment and outcomes for dual eligible beneficiaries with HIV.

Authors:  Nadya Belenky; Brian W Pence; Stephen R Cole; Stacie B Dusetzina; Andrew Edmonds; Jonathan Oberlander; Michael Plankey; Adebola Adedimeji; Tracey E Wilson; Jennifer Cohen; Mardge H Cohen; Joel E Milam; Adaora A Adimora
Journal:  AIDS Care       Date:  2018-09-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.